150 related articles for article (PubMed ID: 11315572)
21. [Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma].
Garrone O; Del Mastro L; Mariani GL; Ardizzoni A; Venturini M; Rosso R
Minerva Med; 1993 Sep; 84(9):467-72. PubMed ID: 7504219
[TBL] [Abstract][Full Text] [Related]
22. Effect of ovariohysterectomy in bitches with mammary neoplasms.
Morris JS; Dobson JM; Bostock DE; O'Farrell E
Vet Rec; 1998 Jun; 142(24):656-8. PubMed ID: 9670443
[TBL] [Abstract][Full Text] [Related]
23. Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas.
Guil-Luna S; Sánchez-Céspedes R; Millán Y; De Andrés FJ; Rollón E; Domingo V; Guscetti F; Martín de Las Mulas J
J Vet Intern Med; 2011; 25(3):518-23. PubMed ID: 21488964
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy.
Cunha SC; Corgozinho KB; Souza HJ; Silva KV; Ferreira AM
J Feline Med Surg; 2015 Dec; 17(12):1000-4. PubMed ID: 25673018
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
Arenas C; Peña L; Granados-Soler JL; Pérez-Alenza MD
Vet Rec; 2016 Jul; 179(5):125. PubMed ID: 27377395
[TBL] [Abstract][Full Text] [Related]
26. Mixed tumors of the canine mammary glands: Evaluation of prognostic factors, treatment, and overall survival.
Nunes FC; Damasceno KA; de Campos CB; Bertagnolli AC; Lavalle GE; Cassali GD
Vet Anim Sci; 2019 Jun; 7():100039. PubMed ID: 32734062
[TBL] [Abstract][Full Text] [Related]
27. FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results.
Pacini P; Rinaldini M; Algeri R; Guarneri A; Tucci E; Barsanti G; Neri B; Bastiani P; Marzano S; Fallai C
Eur J Cancer; 2000 May; 36(8):966-75. PubMed ID: 10885599
[TBL] [Abstract][Full Text] [Related]
28. Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
Mikhak B; Zahurak M; Abeloff MD; Fetting JH; Davidson NE; Donehower RC; Waterfield W; Kennedy MJ
Cancer; 1999 Feb; 85(4):899-904. PubMed ID: 10091768
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
Bang SM; Heo DS; Lee KH; Byun JH; Chang HM; Noh DY; Choe KJ; Bang YJ; Kim SR; Kim NK
Cancer; 2000 Dec; 89(12):2521-6. PubMed ID: 11135211
[TBL] [Abstract][Full Text] [Related]
30. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
Sutton G; Kauderer J; Carson LF; Lentz SS; Whitney CW; Gallion H;
Gynecol Oncol; 2005 Mar; 96(3):630-4. PubMed ID: 15721404
[TBL] [Abstract][Full Text] [Related]
32. Role of body condition score and adiponectin expression in the progression of canine mammary carcinomas.
Tesi M; Millanta F; Poli A; Mazzetti G; Pasquini A; Panzani D; Rota A; Vannozzi I
Vet Med Sci; 2020 Aug; 6(3):265-271. PubMed ID: 32202386
[TBL] [Abstract][Full Text] [Related]
33. Tolerability and pharmacokinetic profile of a novel benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in dogs with malignant mammary tumours.
Kristiansen VM; Dewi S; Horsberg TE; Jonasdottir TJ; Moe L; Berlinger B; Lindkaer-Jensen S; Larsen S
Vet Comp Oncol; 2017 Mar; 15(1):118-132. PubMed ID: 25764447
[TBL] [Abstract][Full Text] [Related]
34. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
[TBL] [Abstract][Full Text] [Related]
35. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
36. Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: a pilot study.
Hermo GA; Torres P; Ripoll GV; Scursoni AM; Gomez DE; Alonso DF; Gobello C
Vet J; 2008 Oct; 178(1):103-8. PubMed ID: 17719812
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
[TBL] [Abstract][Full Text] [Related]
38. Alterations in laboratory test results during adjuvant breast cancer treatment.
Kailajärvi M; Ahokoski O; Virtanen A; Salminen E; Irjala K
Clin Chem Lab Med; 2000 May; 38(5):443-51. PubMed ID: 10952229
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of blood T-lymphocyte subpopulations involved in host cellular immunity in dogs with mammary cancer.
Karayannopoulou M; Anagnostou T; Margariti A; Kostakis C; Kritsepi-Konstantinou M; Psalla D; Savvas I
Vet Immunol Immunopathol; 2017 Apr; 186():45-50. PubMed ID: 28413049
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.
Ryoo BY; Kang YK; Im YH; Kim YJ; Kim BS; Kim TY; Jung SH; Park JH; Baek HJ; Kim YC; Shim YM; Kim CM; Zo JI
Am J Clin Oncol; 1999 Jun; 22(3):253-7. PubMed ID: 10362331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
